FDA Grants Priority Review to Rocket Pharma's Groundbreaking Gene Therapy for Rare LAD-I
FDA Extends Review for Denali's Hunter Syndrome Breakthrough: A Closer Look at Tividenofusp Alfa's Path to Approval
Ascendis Pharma Charts Course for EU Approval of TransCon CNP, Offering New Hope for Achondroplasia
Novo Nordisk's Groundbreaking Hemophilia A Treatment Nears FDA Review
Palvella Therapeutics' QTORIN: A Glimmer of Hope Nears for Pachyonychia Congenita Sufferers
Lion TCR's LioCyx-HBV Secures Historic FDA IND Clearance, Marking a New Era in Chronic Hepatitis B Treatment After Fast Track and Orphan Drug Success
Wave Life Sciences Plummets 19%, But Long-Term Investors See a Silver Lining
A New Dawn for RRP Patients: Papzimeos Secures Landmark FDA Approval, Redefining Care